Cyclobarbital: Difference between revisions
m (Protected "Cyclobarbital": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{Drugbox| | {{Drugbox | ||
|IUPAC_name = ''5-(1-cyclohexenyl)-5-ethyl-1,3-diazinane-2,4,6-trione'' | | Verifiedfields = changed | ||
| image = Cyclobarbital. | | Watchedfields = changed | ||
| width=100 | | verifiedrevid = 460109682 | ||
| | | IUPAC_name = ''5-(1-cyclohexenyl)-5-ethyl-1,3-diazinane-2,4,6-trione'' | ||
| | | image = Cyclobarbital.png | ||
| | | width = 100 | ||
| | | image2 = Cyclobarbital2.png | ||
| | | width2 = 180 | ||
| | |||
<!--Clinical data--> | |||
| Drugs.com = {{Drugs.com|international|cyclobarbital}} | |||
| bioavailability= | | tradename = | ||
| pregnancy_category = | |||
| legal_status = | |||
| routes_of_administration = Oral | |||
<!--Pharmacokinetic data--> | |||
| bioavailability = | |||
| metabolism = [[Hepatic]] | | metabolism = [[Hepatic]] | ||
| elimination_half-life= | | elimination_half-life = | ||
| excretion = [[Renal]] | | excretion = [[Renal]] | ||
| | |||
| | <!--Identifiers--> | ||
| | | CAS_number_Ref = {{cascite|changed|??}} | ||
| CAS_number = 143-76-0 | |||
| ATC_prefix = N05 | |||
| ATC_suffix = CA10 | |||
| PubChem = 5838 | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | |||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | |||
| ChemSpiderID = 5632 | |||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = 0M8A98AD9H | |||
| KEGG_Ref = {{keggcite|changed|kegg}} | |||
| KEGG = D07323 | |||
| ChEMBL_Ref = {{ebicite|correct|EBI}} | |||
| ChEMBL = 268164 | |||
<!--Chemical data--> | |||
| C=12 | H=16 | N=2 | O=3 | |||
| molecular_weight = 236.267 g/mol | |||
| smiles = O=C1NC(=O)NC(=O)C1(/C2=C/CCCC2)CC | |||
| InChI = 1/C12H16N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h6H,2-5,7H2,1H3,(H2,13,14,15,16,17) | |||
| InChIKey = WTYGAUXICFETTC-UHFFFAOYAC | |||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChI = 1S/C12H16N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h6H,2-5,7H2,1H3,(H2,13,14,15,16,17) | |||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChIKey = WTYGAUXICFETTC-UHFFFAOYSA-N | |||
}} | }} | ||
'''Cyclobarbital''', also known as '''cyclobarbitol''' or '''cyclobarbitone''', is a [[drug]] which is a [[barbiturate]] [[derivative (chemistry)|derivative]]. | __NOTOC__ | ||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Cyclobarbital''', also known as '''cyclobarbitol''' or '''cyclobarbitone''', is a [[drug]] which is a [[barbiturate]] [[derivative (chemistry)|derivative]].<ref>{{cite pmid|989475}}</ref> It is primarily available in fixed-dose combination with [[diazepam]] under the brand name '''Reladorm''' (100 mg cyclobarbital + 10 mg diazepam) and is used to treat [[insomnia]] in Russia. | |||
==References== | |||
{{reflist|2}} | |||
{{Hypnotics and sedatives}} | {{Hypnotics and sedatives}} | ||
[[Category:Barbiturates]] | |||
[[Category:Drug]] | |||
[[ | |||
[[ |
Latest revision as of 13:40, 13 April 2015
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C12H16N2O3 |
Molar mass | 236.267 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Cyclobarbital |
Articles |
---|
Most recent articles on Cyclobarbital Most cited articles on Cyclobarbital |
Media |
Powerpoint slides on Cyclobarbital |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cyclobarbital at Clinical Trials.gov Trial results on Cyclobarbital Clinical Trials on Cyclobarbital at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cyclobarbital NICE Guidance on Cyclobarbital
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cyclobarbital Discussion groups on Cyclobarbital Patient Handouts on Cyclobarbital Directions to Hospitals Treating Cyclobarbital Risk calculators and risk factors for Cyclobarbital
|
Healthcare Provider Resources |
Causes & Risk Factors for Cyclobarbital |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cyclobarbital, also known as cyclobarbitol or cyclobarbitone, is a drug which is a barbiturate derivative.[1] It is primarily available in fixed-dose combination with diazepam under the brand name Reladorm (100 mg cyclobarbital + 10 mg diazepam) and is used to treat insomnia in Russia.
References
- ↑ PMID 989475 (PMID 989475)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
- Pages with script errors
- Pages with incomplete PMID references
- Template:drugs.com link with non-standard subpage
- Articles with changed CASNo identifier
- Articles with changed KEGG identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Barbiturates
- Drug